Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

2.0K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
2.0K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

547
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
547
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

392
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
392
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

351
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
351
Respiratory Volumes and Capacities01:22

Respiratory Volumes and Capacities

3.4K
The respiratory system is responsible for the intake of oxygen and the expulsion of carbon dioxide from the body. Respiratory volumes describe the volume of air in the lungs at different phases of the respiratory cycle. Tidal volume is the air breathed in and out during normal, quiet breathing. Inspiratory reserve volume is the air that can be forcefully inspired beyond the tidal volume. In contrast, expiratory reserve volume refers to the air that can be expelled from the lungs after a normal...
3.4K
Vascular Resistance01:20

Vascular Resistance

8.1K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives.

Circulation·2026
Same author

Diaphragm plication reduces sleep-related obstructive disturbances in surgically selected patients with unilateral diaphragmatic dysfunction: pilot observational data.

Respiratory medicine and research·2026
Same author

Reply: <i>FLNA</i> loss-of-function variants in pulmonary hypertension: implications for genetic testing in congenital heart disease.

The European respiratory journal·2026
Same author

Venular remodeling as an integral component of CTEPH Rather Than a Distinct Pathology.

American journal of respiratory and critical care medicine·2026
Same author

Fenfluramine-associated pulmonary hypertension: a study of adverse events reporting system FAERS.

ERJ open research·2026
Same author

Functional and Molecular Characterization of Novel <i>GDF2 (BMP9</i>) and <i>BMP10</i> Variants From the French PAH and HHT Cohorts.

Circulation. Genomic and precision medicine·2026

Related Experiment Video

Updated: Oct 27, 2025

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

13.4K

Ventilatory efficiency in pulmonary vascular diseases.

Jason Weatherald1,2, Brianne Philipenko1, David Montani3,4,5

  • 1Dept of Medicine, Division of Respirology, University of Calgary, Cumming School of Medicine, Calgary, Canada.

European Respiratory Review : an Official Journal of the European Respiratory Society
|July 22, 2021
PubMed
Summary

Cardiopulmonary exercise testing (CPET) reveals ventilatory inefficiency, indicated by high minute ventilation (VE) relative to carbon dioxide output (VCO2), is a key sign of pulmonary vascular diseases. A normal VE/VCO2 ratio helps rule out conditions like pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).

More Related Videos

Characterization of the Isolated, Ventilated, and Instrumented Mouse Lung Perfused with Pulsatile Flow
10:02

Characterization of the Isolated, Ventilated, and Instrumented Mouse Lung Perfused with Pulsatile Flow

Published on: April 29, 2011

16.5K
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.4K

Related Experiment Videos

Last Updated: Oct 27, 2025

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

13.4K
Characterization of the Isolated, Ventilated, and Instrumented Mouse Lung Perfused with Pulsatile Flow
10:02

Characterization of the Isolated, Ventilated, and Instrumented Mouse Lung Perfused with Pulsatile Flow

Published on: April 29, 2011

16.5K
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.4K

Area of Science:

  • Cardiology
  • Pulmonology
  • Exercise Physiology

Background:

  • Cardiopulmonary exercise testing (CPET) is crucial for diagnosing dyspnea.
  • Ventilatory inefficiency (high VE/VCO2) is characteristic of pulmonary vascular diseases.
  • Mechanisms include high dead space, altered chemosensitivity, and CO2 set-point.

Purpose of the Study:

  • To highlight the diagnostic significance of ventilatory inefficiency in CPET.
  • To emphasize the role of VE/VCO2 in identifying pulmonary vascular diseases.
  • To discuss the prognostic value of VE/VCO2 in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).

Main Methods:

  • Analysis of ventilatory and gas exchange data during CPET.
  • Evaluation of the VE/VCO2 ratio as a diagnostic marker.
  • Correlation of VE/VCO2 with specific pulmonary vascular diseases.

Main Results:

  • A normal VE/VCO2 ratio makes pulmonary vascular diseases unlikely.
  • Elevated VE/VCO2 warrants further investigation for PAH or CTEPH, especially with risk factors.
  • VE/VCO2 can be a prognostic marker in established PAH/CTEPH and may improve with treatment.

Conclusions:

  • Ventilatory inefficiency (high VE/VCO2) is a significant indicator in CPET for pulmonary vascular diseases.
  • CPET findings, particularly the VE/VCO2 ratio, aid in diagnosing and assessing PAH and CTEPH.
  • Further research is needed to determine the full value of VE/VCO2 in longitudinal patient follow-up.